AKTUALNIE REKRUTUJĄCE BADANIA
Badania prowadzone są w ośrodkach badań klinicznych PRATIA
Chłoniak z małych limfocytów SLL
NAZWA BADANIA
OPIS BADANIA
OŚRODKI PROWADZĄCE
NAZWA BADANIA
OPIS BADANIA
"A Phase 3 Open-Label, Randomized Study of LOXO-305 versus Investigator’s Choice of Idelalisib plus Rituximab or Bendamustine plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)."
NAZWA BADANIA
OPIS BADANIA
A Phase 3 Open-Label, Randomized Study of Fixed Duration Pirtobrutinib (LOXO-305) plus Venetoclax and Rituximab versus Venetoclax and Rituximab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN-CLL-322)
NAZWA BADANIA
OPIS BADANIA
A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (MAJIC)
NAZWA BADANIA
OPIS BADANIA
"A Phase 3 Open-Label, Randomized Study of Pirtobrutinib (LOXO-305) versus Ibrutinib in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN-CLL-314)"
NAZWA BADANIA
OPIS BADANIA
"A Phase 3, Randomized Study to Compare the Efficacy and Safety of Nemtabrutinib Versus Chemoimmunotherapy for Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Without TP53 Aberrations (BELLWAVE-008)"
W tym obszarze czytaj więcej:
Menu
